These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Near infrared photoimmunotherapy for lung metastases. Sato K; Nagaya T; Mitsunaga M; Choyke PL; Kobayashi H Cancer Lett; 2015 Aug; 365(1):112-21. PubMed ID: 26021765 [TBL] [Abstract][Full Text] [Related]
23. Comparison of low-molecular-weight ligand and whole antibody in prostate-specific membrane antigen targeted near-infrared photoimmunotherapy. Nakajima K; Miyazaki F; Terada K; Takakura H; Suzuki M; Ogawa M Int J Pharm; 2021 Nov; 609():121135. PubMed ID: 34571072 [TBL] [Abstract][Full Text] [Related]
24. Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models. Shiravi F; Mohammadi M; Golsaz-Shirazi F; Bahadori T; Judaki MA; Fatemi F; Zare HA; Haghighat FN; Mobini M; Jeddi-Tehrani M; Amiri MM; Shokri F Invest New Drugs; 2021 Jun; 39(3):697-704. PubMed ID: 33389387 [TBL] [Abstract][Full Text] [Related]
25. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer. Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903 [TBL] [Abstract][Full Text] [Related]
26. Near infrared photoimmunotherapy with an anti-mesothelin antibody. Nagaya T; Nakamura Y; Sato K; Zhang YF; Ni M; Choyke PL; Ho M; Kobayashi H Oncotarget; 2016 Apr; 7(17):23361-9. PubMed ID: 26981775 [TBL] [Abstract][Full Text] [Related]
27. Strongly enhanced antitumor activity of trastuzumab and pertuzumab combination treatment on HER2-positive human xenograft tumor models. Scheuer W; Friess T; Burtscher H; Bossenmaier B; Endl J; Hasmann M Cancer Res; 2009 Dec; 69(24):9330-6. PubMed ID: 19934333 [TBL] [Abstract][Full Text] [Related]
28. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer. Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755 [TBL] [Abstract][Full Text] [Related]
29. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy. Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257 [TBL] [Abstract][Full Text] [Related]
30. Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer. Yamaguchi H; On J; Morita T; Suzuki T; Okada Y; Ono J; Evdokiou A Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830099 [TBL] [Abstract][Full Text] [Related]
31. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody. Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622 [TBL] [Abstract][Full Text] [Related]
32. MRP1-targeted near infrared photoimmunotherapy for drug resistant small cell lung cancer. Li F; Mao C; Yeh S; Sun Y; Xin J; Shi Q; Ming X Int J Pharm; 2021 Jul; 604():120760. PubMed ID: 34077781 [TBL] [Abstract][Full Text] [Related]
33. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy. Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765 [TBL] [Abstract][Full Text] [Related]
34. Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer. Maawy AA; Hiroshima Y; Zhang Y; Heim R; Makings L; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M PLoS One; 2015; 10(3):e0121989. PubMed ID: 25799218 [TBL] [Abstract][Full Text] [Related]
35. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Mitsunaga M; Ogawa M; Kosaka N; Rosenblum LT; Choyke PL; Kobayashi H Nat Med; 2011 Nov; 17(12):1685-91. PubMed ID: 22057348 [TBL] [Abstract][Full Text] [Related]
36. Phototoxicity in near-infrared photoimmunotherapy is influenced by the subcellular localization of antibody-IR700. Nakajima K; Ogawa M Photodiagnosis Photodyn Ther; 2020 Sep; 31():101926. PubMed ID: 32717450 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green. Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H Cancer Sci; 2021 Mar; 112(3):1326-1330. PubMed ID: 33543819 [TBL] [Abstract][Full Text] [Related]
38. Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models. Yamashita-Kashima Y; Iijima S; Yorozu K; Furugaki K; Kurasawa M; Ohta M; Fujimoto-Ouchi K Clin Cancer Res; 2011 Aug; 17(15):5060-70. PubMed ID: 21700765 [TBL] [Abstract][Full Text] [Related]
39. Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti-CD44-Based NIR-PIT. Nagaya T; Nakamura Y; Okuyama S; Ogata F; Maruoka Y; Choyke PL; Allen C; Kobayashi H Mol Cancer Res; 2017 Dec; 15(12):1667-1677. PubMed ID: 28923838 [TBL] [Abstract][Full Text] [Related]
40. 3D mesoscopic fluorescence tomography for imaging micro-distribution of antibody-photon absorber conjugates during near infrared photoimmunotherapy in vivo. Tang Q; Nagaya T; Liu Y; Horng H; Lin J; Sato K; Kobayashi H; Chen Y J Control Release; 2018 Jun; 279():171-180. PubMed ID: 29673644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]